ALXN
Alexion Pharmaceuticals Inc
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
700 hedge funds and large institutions have $22.4B invested in Alexion Pharmaceuticals Inc in 2020 Q2 according to their latest regulatory filings, with 122 funds opening new positions, 245 increasing their positions, 247 reducing their positions, and 66 closing their positions.
Holders
700
Holders Change
+51
Holders Change %
+7.86%
% of All Funds
14.39%
Holding in Top 10
21
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+10.53%
% of All Funds
0.43%
New
122
Increased
245
Reduced
247
Closed
66
Calls
$305M
Puts
$378M
Net Calls
-$72.3M
Net Calls Change
+$15.6M
Top Buyers
| 1 |
1
LSV Asset Management
Chicago,
Illinois
|
$393M |
| 2 |
2
BlackRock
New York
|
$2.08B |
| 3 |
3
Fidelity Investments
Boston,
Massachusetts
|
$1.46B |
| 4 |
4
First Trust Advisors
Wheaton,
Illinois
|
$220M |
| 5 |
5
JPMorgan Chase & Co
New York
|
$429M |
